PRU vs TCRT · rev $31.19B vs $5.6M cap
PRU (PRU) versus Alaunos Therapeutics Inc (TCRT) — a side-by-side from cached financials, not a winner call.
PRU (PRU) common stock.
Alaunos Therapeutics Inc (TCRT) is a biotechnology company listed on NASDAQ.
Latest reported PRU revenue for 2026-06-30 was $31.19B. Net income was $1.58B. PRU currently screens at market cap $0.
Latest reported TCRT revenue for 2026-06-30 was $0. Net income was -$2.0M. TCRT currently screens at market cap $5.6M.
PRU currently screens at market cap $0. TCRT currently screens at market cap $5.6M.
Not investment advice. Open the PRU and TCRT stock pages for the full models.
Not investment advice.